Everest Group (EG) Stock May Be Cheap On Mexico Unit Sale
Everest Group has delivered a 51.7% total return over the past five years, yet the share price recently eased back and the valuation checks still suggest the stock leans cheap rather than stretched.
- Over five years, a 51.7% return points to shareholder value creation that now has investors asking whether the current price still offers a margin of safety.
- The planned sale of Everest Group's Mexico insurance operations to Fairfax can help sharpen the focus on core reinsurance and wholesale franchises, while execution risk around this reshaping of the business may influence how much investors are willing to pay for the stock.
- Everest Group screens as undervalued on most of Simply Wall St's checks, with the stock passing 5 out of 6 valuation tests, which tilts the overall picture toward a discount rather than a full price.
The stock's next move may depend on whether the market continues to price Everest Group as a discount opportunity or starts to close that gap.
Is Everest Group Still Cheap on Earnings?
The P/E ratio is a useful yardstick for Everest Group because earnings remain a main driver of returns for an insurance and reinsurance business. Everest Group currently trades on a P/E of 7.5x, which is slightly below the peer average of 7.9x and well below the broader insurance industry average of 11.5x. That positions the stock at a modest earnings discount to both its closest peers and the wider sector.
The fair P/E ratio implied by Simply Wall St’s model is 13.0x. This reflects what investors might pay for Everest Group given its profitability profile, industry, size and risk factors. The gap between this fair ratio and the current 7.5x is wide, which points to the market assigning a lower earnings multiple than the model suggests. Despite the agreed sale of the Mexico insurance operations to Fairfax, which could help simplify Everest Group’s focus, the stock is still priced at a discount on this earnings measure.
On the P/E multiple alone, Everest Group appears undervalued compared with both modelled fair value and sector benchmarks.
See what the numbers say about this price — find out in our valuation breakdown.
The Everest Group Narrative: What Would Justify Today's Price?
Simply Wall St Narratives pick up where the Everest Group valuation puzzle leaves off and explain which earnings, margin and growth paths would need to play out for the stock to look meaningfully under or overvalued compared with today’s price. Each narrative ties its number to a concrete view of how Everest Group's growth, profitability and risks could evolve, which you can revisit on the Community page as fresh information becomes available.
You can be one of the first voices in the Simply Wall St community to set out a number driven case on Everest Group's stock, including a view on whether the planned sale of Everest Group's Mexico insurance operations to Fairfax ultimately delivers the focus the company is aiming for. Share a Narrative, pin a clear valuation and risk thesis to that transaction and Everest Group's core franchises, and track how it holds up as new results and updates arrive.
Do you think there's more to the story for Everest Group? Head over to our Community to see what others are saying!
The Bottom Line
Everest Group screens as undervalued on earnings, with the current P/E sitting below both close peers and the wider insurance industry. The valuation case now rests on whether that discount narrows or proves to be a lasting feature. The planned sale of the Mexico insurance operations highlights the key question for investors. The crux is whether Everest Group can keep executing on its refocused reinsurance and wholesale strategy well enough for the market to reassess the multiple, rather than treating the current discount as justified.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com